PDZK1, un objetivo directo de Gli2, promueve el tráfico de FGFR3 y la proliferación celular en el cáncer colorrectal.

In colorectal cancer (CRC), dysregulated Hedgehog (Hh) and fibroblast growth factor receptor 3 (FGFR3)-related pathways drive tumor progression, but their molecular crosstalk remains poorly understood. Here, we demonstrate that the scaffold protein PDZ domain-containing1 (PDZK1) is significantly upregulated in CRC and associated with poor patient prognosis. Functionally, PDZK1 promotes CRC cell proliferation by serving as a direct transcriptional target of Gli family zinc finger 2 (Gli2), the key effector of Hh signaling. Knockdown of PDZK1 markedly attenuated Gli2-driven oncogenic effects, whereas enforced PDZK1 expression rescued the growth inhibition induced by Gli2 silencing, confirming its essential role in Hh signaling-mediated malignancy.

Mechanistically, PDZK1 physically interacts with FGFR3 and facilitates its membrane trafficking, thereby enhancing receptor availability and downstream activation of AKT and STAT3 signaling.

Our findings reveal PDZK1 as a critical oncogenic scaffold bridging Hh and FGFR3-related pathways in CRC, offering a potential therapeutic target for intervention.